Cleveland Medical Devices Inc. has been awarded $60,000 from the Cuyahoga County New Product Development and Entrepreneurship Loan Fund to step up commercialization of its SleepView device for sleep apnea screening at home.
CleveMed has a lineup of wireless diagnostic sleep systems, including SleepView, which is the smallest and lightest home sleep monitor with an American Academy of Sleep Medicine-recommended Type 3 channel set.
“This is all about, how do we start to commercialize this more?” said Bob Schmidt, CleveMed chairman. “We want to expand from the hundreds of places [where the device is used] now to thousands of places.”
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
CleveMed develops innovative biomedical signal processing and instrumentation devices for sleep and movement disorders, like Parkinson’s.
The Cuyahoga County loan fund is administered by the Manufacturing Advocacy & Growth Network, better known as MAGNET. Twelve companies, including Cleveland Medical Devices, will receive $470,000 from the latest round of funding from the program.
